Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
ipo
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
cancer
cancer drugs
clinical trials
revolution medicines
san francisco
sanofi
the column group
third rock ventures
venture capital
warp drive bio
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amgen
amicus therapeutics
approval
apremilast
base editing
bio
biogen
biome
blueprint medicineas
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
celgene
cervical cancer
clinical study
What
cancer
3
×
ipo
3
×
medicines
proteins
research
revolution
allogene
bio
cancer’s
crispr
despite
disease
diversity
drug
family
frontiers
hardest
hit
hot
hottest
hunters
immunotherapy
investors
juno
known
maps
million
nearly
new
parlance
pharmaceutical
play
ras
reach
reels
remains
revealed
role
roundup
shares
Language
unset
Current search:
ipo
×
cancer
×
ipo
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More